FDA — authorised 29 September 1995
- Application: NDA020489
- Marketing authorisation holder: ABBVIE
- Local brand name: ANDRODERM
- Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
- Status: approved
🇺🇸 Androderm® in United States
FDA authorised Androderm® on 29 September 1995
Marketing authorisation
Other Endocrinology approved in United States
Frequently asked questions
Is Androderm® approved in United States?
Yes. FDA authorised it on 29 September 1995.
Who is the marketing authorisation holder for Androderm® in United States?
ABBVIE holds the US marketing authorisation.